Biofrontera AG operates as a biopharmaceutical company, which engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.
![Biofrontera logo](/files/LOGO/1729244-BFRA.png)
Company profile
Ticker
BFRA
Exchange
Website
CEO
Hermann Lübbert
Employees
Location
SEC CIK
BFRA stock data
Latest ownership filings
No filings